| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 26,660 | 13,274 | 15,597 | 16,784 | | Cost of Revenue | 21,382 | 15,131 | 15,936 | 20,754 | | | Gross Profit | 5,278 | (1,857) | (339) | (3,970) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 6,335 | 9,656 | 10,076 | 19,320 | | Non Recurring |
-
| 16,156 |
-
| 10,634 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,057) | (27,669) | (10,415) | (33,924) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 107 | 195 | 183 | 306 | | Earnings Before Interest And Taxes | (23,744) | (50,737) | (11,362) | (78,903) | | Interest Expense | 2,749 | 3,067 | 1,476 | (887) | | Income Before Tax | (26,493) | (53,804) | (12,838) | (78,016) | | Income Tax Expense | (1,007) | 415 | 385 | (7,457) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (72,673) | (54,219) | (13,223) | (70,559) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (25,486) | (54,219) | (13,223) | (70,559) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($25,486) | ($54,219) | ($13,223) | ($70,559) |
|
0.31% Nasdaq 0.00%
Income Statement
